Key findings
TNF-α, inflammation, physical stiffness, arthritis, pain, joint stiffness
INFLAMMATION, ARTHRITIS
The findings of the present randomized, open-label interventional trial showed that PeaNoc XL tablets help in the reduction of pain, joint stiffness, and physical stiffness (WOMAC questionnaire).Inflammatory levels of TNF-α, IL1-β, IL-6, and CRP levels in patients with joint pain and inflammation were significantly reduced in PeaNoc XL add-on treatment as compared to baseline and standard therapy.A 12- week supplementation of PeaNoc XL add-on therapy was effective in arthritis patients with joint pain and inflammation.PeaNoc XL was well-tolerated as an add-on oral therapy, suggesting its safety and efficacy.